Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Sells $345,400.00 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Lori Anne Kunkel sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $34.54, for a total transaction of $345,400.00. Following the completion of the transaction, the director owned 51,884 shares in the company, valued at approximately $1,792,073.36. This trade represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Price Performance

Shares of IMRA opened at $16.91 on Friday. The firm has a market cap of $3.21 million, a P/E ratio of 338.20 and a beta of 2.88. The stock has a 50 day simple moving average of $16.04 and a two-hundred day simple moving average of $15.92. Bitwise MARA Option Income Strategy ETF has a 1 year low of $11.99 and a 1 year high of $54.94.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.